UK researchers have created a metal-based molecule that inhibits the build-up of Alzheimer’s-associated peptide, amyloid-β, in lab tests.
List view / Grid view
Imperial College London
A new artificial intelligence (AI) method has been created to uncover which proteins enable bacteria to infect human intestines.
Biliverdin attaches to a region of the SARS-CoV-2 Spike protein, stabilising it so that it is not able to expose its structure to antibodies, a new study has shown.
The multiple serotypes of rhinovirus have presented difficulties for vaccine developers. Now, a team led by Professor Gary McLean from London Metropolitan University and Imperial College London, alongside Professor Sebastian Johnston from Imperial, has formulated a potential vaccine. Nikki Withers spoke to McLean to discover how the vaccine works and…
The UK Government will give £18.5 million in funding to four studies researching the causes and potential treatments of long COVID.
A better understanding of the role of four-stranded DNA (G-quadruplex) could enhance cancer therapeutics, said the developers of the probes.
A total of 21 COVID-19 research projects have been granted funding by the UK government, including vaccine and therapeutic development.
A study has revealed that activation of syndecan-4 sensory protrusions extending from cells may be a future target for cancer therapy.
A new mechanism by which cancer cells become resistant to chemotherapy has been found which could lead to a new target for drugs.
New antibiotics could be designed by discovering the mechanism a weapon bacteria uses to vanquish their competitors.
A new study shows that using therapeutic antibodies to block the interleukin-11 protein can reverse idiopathic pulmonary fibrosis.
Scientists have shown that drug-resistant bacteria infections shut out antibiotics by closing tiny doors in their cell walls.
Breast cancer medicines may force some cancer cells into 'sleeper mode', allowing them to potentially come back to life after treatment.